Increased galectin-3 expression has been documented in cardiovascular diseases (CVDs), such as atherosclerosis, acute ischemic stroke, acute coronary syndrome (ACS) and heart failure (HF), arterial hypertension, cardiomyopathies or atrial fibrillation (AF) [19] (Figure 2). This evidence concerns the gene LGALS3 and atherosclerosis.